XKRX
003350
Market cap219mUSD
Oct 08, Last price
16,240.00KRW
1D
-3.51%
1Q
102.24%
Jan 2017
-40.62%
Name
Hankook Cosmetics Manufacturing Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hankook Cosmetics Manufacturing Co., Ltd., established in Seoul, South Korea, in 1962, is dedicated to the global research, development, and production of a wide array of cosmetic and personal care products. Their comprehensive offerings span numerous categories, including an extensive selection of skin and body care items such as hydrating waters, creams, facial masks, various cleansing formulations (powders, liquids, masks), oils, lotions, and powders. The company also formulates color cosmetics like blushers, facial powders, foundations, makeup bases, fixatives, lipsticks, and lip gloss, alongside functional products designed for anti-aging, skin brightening, and UV protection. Catering to men's grooming needs, they provide aftershave, pre-shave, shaving creams, beard conditioners, and related shaving essentials. For infants, a dedicated baby care line features gentle shampoos, body cleansers, lotions, creams, sun protection, and oils. Beyond these, Hankook Cosmetics offers a diverse range of fragrances, including perfumes, powdered perfumes, scented sachets, and shower colognes. Their expansive hair care portfolio covers everything from shampoos, rinses, and conditioners to tonics, styling aids like gels, waxes, sprays, and mousses, as well as specialized treatments and straighteners. In addition to manufacturing, the company also provides consulting services.
Key people
Co-Chairman · since 2022
Co-Chairman · since 2023
Chief Executive Officer, Vice Chairman · since 2022
Eun Tae Lee
Vice President · since 2022
Jin Seong Kang
Managing Director · since 2023
Jin Wuk Yim
Managing Director
Byeong Hun Hyun
Internal Auditor · since 2024
Vice President, Director · since 2022
Sang Suk Choi
Non-Executive Independent Director · since 2021
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||